U.S. President Donald Trump on Tuesday announced that drug maker Pfizer had agreed to provide prescription medications to Medicaid at most-favored-nation prices, matching the lowest prices offered in other developed nations. The company will also invest $70 billion in U.S. manufacturing and research and development.
Trump Announces Pfizer Deal to Lower Drug Prices